Drug data last refreshed 4h ago · AI intelligence enriched 2w ago
Talc is an intrapleural powder used for pleurodesis, a procedure that prevents fluid recurrence in the pleural space by causing inflammation and adhesion of pleural surfaces. It is indicated for patients with malignant pleural effusions or recurrent pneumothorax who require definitive management. The drug works through a physical irritant mechanism that promotes fibrosis and obliteration of the pleural cavity.
With LOE approaching and minimal linked job count, this product faces declining revenue and reduced team investment opportunities.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Study on Hydrotalcite for Relief of Acid Symptoms Due to Acid Rebound After Stopping Long-Term PPI Therapy
AMPLE-3: IPC Plus Talc vs VATS in Management of Malignant Pleural Effusion
Out Patient Talc Slurry Via Indwelling Pleural Catheter for Malignant Pleural Effusion Vs Usual Inpatient Management
Placebo Controlled Phase IV Study to Compare the Efficacy and Safety of a Single Dose of Oral Talcid, a Single Dose of Oral Famotidine and a Single Dose of Placebo in Patients With Acute Heartburn Episodes
Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma
Worked on TALC at Innova Therapeutics? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Talc currently has zero linked job openings, reflecting its position as a mature, specialty intrapleural therapy with limited commercial momentum. Career growth on this product is constrained by approaching LOE and absence of development or expansion initiatives.